Does higher usage of low-cost statins correlate with a poorer achievement in cholesterol quality markers for secondary prevention?-Reference-Cited by-同舟云学术

Does higher usage of low-cost statins correlate with a poorer achievement in cholesterol quality markers for secondary prevention?

Published:2010-01-01 Issue:570 Volume:60 Page:50-52
ISSN:0960-1643
Container-title:British Journal of General Practice
language:en
Short-container-title:Br J Gen Pract

Author:

Hickman James

Publisher

Royal College of General Practitioners

Subject

Family Practice

Reference6 articles.

1. National Institute for Health and Clinical Excellence (2006) NICE Technology Appraisal Ta94. Cardiovascular disease — statins (NICE, London) http://www.nice.org.uk/nicemedia/pdf/TA094quickrefguide.pdf (accessed 28 Oct 2009).

2. NHS Institute for Innovation and Improvement NHS indicators, http://www.productivity.nhs.uk/Definitions.aspx (accessed 2 Nov 2009).

3. Somerset Primary Care Trust (2007) Specification for a local enhanced service 3.2. practice based commissioning (Somerset Primary Care Trust, Yeovil).

4. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial);Jones;Am J Cardiol,2003

5. National Institute for Health and Clinical Excellence (2007) NICE Technology Appraisal Ta132. Hypercholesterolaemia — ezetimibe (NICE, London) http://guidance.nice.org.uk/TA132 (accessed 2 Nov).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption;European Journal of Medicinal Chemistry;2022-02

2. Achievement of cholesterol targets and prescribing of higher-cost statins: a cross-sectional study in general practice;British Journal of General Practice;2012-12

3. Generic and therapeutic substitutions in the UK: are they a good thing?;British Journal of Clinical Pharmacology;2010-06-01